Anzeige
Mehr »
Samstag, 28.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Cantech Letter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
05.06.Is Riot Platforms a buy right now?
05.06.Yext stock is a buy, this analyst says
04.06.Is VersaBank stock a buy?
04.06.Blackline Safety keeps "Buy" rating at ATB Capital
03.06.Loop Industries keeps "Buy" rating at Paradigm Capital
03.06.Groupon earns another price target raise at Roth
03.06.Is Cresco Labs a buy right now?
03.06.Baylin Technologies price target cut at Paradigm
03.06.Canopy Growth has price target chopped at Roth
02.06.Xtract One Technologies is "scaling exactly as it should", analyst says
01.06.Trubar wins price target raise at Clarus Securities
01.06.CHAR Technologies has price target chopped at Paradigm, keeps "Buy" rating
30.05.Rubicon Organics is undervalued, this analyst says
30.05.Electrovaya is a "Strong Buy", Raymond James says
29.05.Stifel remains bullish on ATS
29.05.Is TeraWulf stock a buy right now?
29.05.Constellation Software has delivered a 36,000% return since its IPO. Is it still a buy?
28.05.Imaflex stock is undervalued, this analyst says
28.05.Analyst ups his price target on KITS Eyecare
28.05.Xtract One Technologies is a buy, Ventum says
27.05.Tornado Infrastructure Equipment is a buy, Beacon says
26.05.Now is not the time to buy Target stock, this analyst says
26.05.DMG Blockchain Solutions is a buy, Roth says
25.05.Wishpond Technologies keeps "Buy" rating at Beacon Securities
25.05.NowVertical Group wins price target raise at Ventum